FOUNTAIN BIOPHARMA INC has a total of 24 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2013. It filed its patents most often in Taiwan, United States and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SYNTONIX PHARMACEUTICALS INC, CREATIVE PEPTIDES SWEDEN AB and MEDIMMUNE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 4 | |
#2 | United States | 4 | |
#3 | China | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Fermentation | |
#6 | Enzymes | |
#7 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Lin Willie | 9 |
#2 | Town Winston | 9 |
#3 | Chen Nien-Yi | 9 |
#4 | Tsao Tanny Chen | 7 |
#5 | Wu Han-Chung | 6 |
#6 | Chen Hung-Chi | 6 |
#7 | Wu Che-Haorz | 6 |
#8 | Lee Tong-Young | 4 |
#9 | Lu Kung-Ming | 3 |
#10 | Cheng Tien-Tien | 3 |
Publication | Filing date | Title |
---|---|---|
TW202014518A | Nucleic acid aptamers targeting lymphocyte activation gene 3 (lag-3) and uses thereof | |
TW201623620A | Methods for producing recombinant glycoproteins with modified glycosylation | |
WO2014066167A1 | Antibodies to interleukin-6 and uses thereof |